GENERATION OF REACTIVE OXYGEN SPECIES AND ACTIVITY OF PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN HUMAN MONOCYTE-DERIVED MACROPHAGES

被引:0
|
作者
RUSSWURM, S
KRAUSE, S
FINKELBERG, L
RUHLING, K
SCHAUER, U
LOSCHE, W
机构
[1] UNIV JENA, FAC MED, VASC BIOL RES CTR, D-99089 ERFURT, GERMANY
[2] ERFURT HOSP, DEPT MED, D-99089 ERFURT, GERMANY
关键词
ATHEROSCLEROSIS; MONOCYTES; MACROPHAGES; PAF-ACETYLHYDROLASE; HYPERLIPEMIA; REACTIVE OXYGEN SPECIES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monocytes were prepared from healthy human volunteers and were allowed to differentiate into macrophages by adhesion to plastic surface and cultured over 7 days in presence of either 10 % fetal calf serum (FCS), human control serum or serum from hyperlipaemic patients. Hyperlipaemic serum stimulated the differentiation (measured as an increase in cellular protein and DNA content) to a higher extent when compared to control serum and FCS. With all sera a marked increase of the cellular activity of the enzyme platelet-activating factor acetylhydrolase (PAF-AH) and a tremendous decrease in the capacity of cells to generate reactive oxygen species (ROS) was observed. After seven days of culture the increase in PAH-AH activity was about 19-fold with hyperlipaemic serum, 11-fold with control serum and 6-fold with FCS. During the same period of time ROS generation measured as zymosan-induced chemiluminescence decreased by about 98 % and no significant differences between the three types of serum were found. The results indicate that the activity of PAF-AH and the capacity of ROS generation which are both assumed to play an important role in the oxidation of low-density lipoproteins (LDL) and thus in the development of atherosclerosis, change in opposite direction during the differentiation of blood monocytes into macrophages, and that hyperlipaemic serum stimulates PAF-AH activity but not ROS generation.
引用
收藏
页码:505 / 514
页数:10
相关论文
共 50 条
  • [11] EFFECTS OF ENDOTOXINS AND CYTOKINES ON THE SECRETION OF PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE BY HUMAN DECIDUAL MACROPHAGES
    NARAHARA, H
    JOHNSTON, JM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (03) : 531 - 537
  • [12] PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE ACTIVITY IN HUMAN TISSUES AND BLOOD-CELLS
    STAFFORINI, DM
    PRESCOTT, SM
    ZIMMERMAN, GA
    MCINTYRE, TM
    LIPIDS, 1991, 26 (12) : 979 - 985
  • [13] PLATELET ACTIVATING FACTOR-STIMULATED CALCIUM INFLUX IN MONOCYTE-DERIVED MACROPHAGES
    KATNIK, C
    NELSON, DJ
    FASEB JOURNAL, 1992, 6 (01): : A512 - A512
  • [14] PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE ACTIVITY IN BOVINE SEMINAL PLASMA
    PARKS, JE
    HOUGH, SR
    JOURNAL OF ANDROLOGY, 1993, 14 (05): : 335 - 339
  • [15] PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE ACTIVITY IN NORMOTENSIVE AND HYPERTENSIVE PREGNANCIES
    MAKI, N
    MAGNESS, RR
    MIYAURA, S
    GANT, NF
    JOHNSTON, JM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (01) : 50 - 54
  • [16] OXYGEN RADICALS INHIBIT HUMAN PLASMA ACETYLHYDROLASE, THE ENZYME THAT CATABOLIZES PLATELET-ACTIVATING-FACTOR
    AMBROSIO, G
    ORIENTE, A
    NAPOLI, C
    PALUMBO, G
    CHIARIELLO, P
    MARONE, G
    CONDORELLI, M
    CHIARIELLO, M
    TRIGGIANI, M
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06): : 2408 - 2416
  • [17] PURIFICATION OF HUMAN-PLASMA PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE
    STAFFORINI, DM
    PRESCOTT, SM
    MCINTYRE, TM
    CLINICAL RESEARCH, 1986, 34 (01): : A41 - A41
  • [18] HUMAN PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE EXPRESSED IN XENOPUS OOCYTES
    YAMADA, Y
    STAFFORINI, DM
    FITZGERALD, LA
    ZIMMERMAN, GA
    MCINTYRE, TM
    PRESCOTT, SM
    CLINICAL RESEARCH, 1992, 40 (02): : A201 - A201
  • [19] PURIFICATION OF HUMAN-PLASMA PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE
    STAFFORINI, DM
    PRESCOTT, SM
    MCINTYRE, TM
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1530 - 1530
  • [20] INTERFERON-GAMMA DECREASES PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE SECRETION BY MACROPHAGES
    ELSTAD, MR
    STAFFORINI, DM
    MCINTYRE, TM
    PRESCOTT, SM
    ZIMMERMAN, GA
    CLINICAL RESEARCH, 1991, 39 (02): : A397 - A397